Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics, Treatment Regimens and Survival in Elderly Patients with AL Amyloidosis in a Tertiary Referral Center

Jose Acevedo, Gheorghe Doros, PhD, Raphael Szalat, John Mark Sloan, MD, Shayna Sarosiek, Vaishali Sanchorawala, MD

Blood (2019) 134 (Supplement_1): 5447.

https://doi.org/10.1182/blood-2019-124980

Published: 2019

Journal Articles

Localized Pulmonary Amyloidosis: A Single Institution Experience

Ajay Tambe, MBBS, Poornima Ramadas, MBBS, Mijung Lee, MD, Kanish Mirchia, MD

Blood (2019) 134 (Supplement_1): 5464.

https://doi.org/10.1182/blood-2019-125124

Published: 2019

Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD

Blood (2019) 134 (Supplement_1): 5566.

https://doi.org/10.1182/blood-2019-129002

Published: 2019

Journal Articles

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Ana Carolina Oliver, MD, Roberto Superchi, MD, Superchi Federico, MD, Canabal Matilde, MD, Jubin Silvana, Lic, Carolina Errecarte, MD, Caneiro Ada, MD, Silvia Pierri, MD, Sebastian Galeano, MD, Eloisa Riva, MD, Bello Laura, MD, Regis Gai, MD, Miller Andrew, MD, Pablo J. Muxi, MD, Ricardo Fabian Mosquera, MD

Blood (2019) 134 (Supplement_1): 5688.

https://doi.org/10.1182/blood-2019-127680

Published: 2019

Journal Articles

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Blood (2019) 134 (Supplement_1): 3034.

https://doi.org/10.1182/blood-2019-128850

Published: 2019

Journal Articles

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

Eli Muchtar, Shaji K. Kumar, Morie A. Gertz, Martha Grogan, Omar F. AbouEzzeddine, Allan S. Jaffe, Angela Dispenzieri

Blood (2019) 133 (7): 763–766.

https://doi.org/10.1182/blood-2018-10-875252

Published: 2019

Includes: Supplemental data

Journal Articles

Prognosis of Patients with Waldenström Macroglobulinemia: A Simplified Model

Saurabh Zanwar, MBBS, Jithma Prasad Abeykoon, MD, Stephen M. Ansell, MD PhD, Angela Dispenzieri, MD, Morie A. Gertz, MD, David J Inwards, MD, Thomas E. Witzig, MD, Martha Q. Lacy, MD, Thomas M. Habermann, MD, David Dingli, MD PhD, Francis K. Buadi, MB, CHB, Ronald S. Go, MD, Wilson I Gonsalves, MD, Eli Muchtar, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, Prashant Kapoor, MD

Blood (2018) 132 (Supplement 1): 4152.

https://doi.org/10.1182/blood-2018-99-119849

Published: 2018

Journal Articles

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Camila Peña, MD, Gonzalo P Mendez, MD, Natalia Paola Schutz, MD, Eloisa Riva, MD, Ricardo Valjalo, MD, Hernán López-Vidal, MD, Alejandro Majlis, MD, Vivianne Lois, MD, Daniela Zamora, MD, Jose T Gonzalez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 5856.

https://doi.org/10.1182/blood-2018-99-113198

Published: 2018

Journal Articles

Personalizing Amyloidosis Therapy with Real Time PET Imaging of Fibril-Reactive Monoclonal Antibody Cael-101

Jing Fu, PhD, Alan Solomon, MD, Patrick Carberry, PhD, John Castrillon, Jongho Kim, MD PhD, Suzanne Lentzsch, MD PhD, Akiva Mintz, MD PhD

Blood (2018) 132 (Supplement 1): 1003.

https://doi.org/10.1182/blood-2018-99-118177

Published: 2018

Journal Articles

Risk Stratification of Smoldering Multiple Myeloma in the Light of the Revised IMWG Diagnostic Criteria

Blood (2017) 130 (Supplement 1): 4384.

https://doi.org/10.1182/blood.V130.Suppl_1.4384.4384

Published: 2017

Journal Articles

Patterns of Treatment Failure in Systemic Light Chain Amyloidosis with Long-Term Survival after Chemotherapy

Hee Kyung Kim, MD, Kihyun Kim, MD PhD, Lee Hansang, Heo Mi Hwa, Park Silvia

Blood (2016) 128 (22): 2132.

https://doi.org/10.1182/blood.V128.22.2132.2132

Published: 2016

Journal Articles

Outcome of Very Young (≤ 40 years) Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Case Control Study

Jithma P Abeykoon, MD, Miriam Hobbs, CNP, Jonas Paludo, MD, Dirk R Larson, MS, Angela Dispenzieri, MD, Morie A. Gertz, MD, Francis K. Baudi, S. Vincent Rajkumar, MD, David Dingli, MD PhD FRCP, Wilson I Gonsalves, MD, Nelson Leung, MD, Robert A. Kyle, MD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Taxiarchis Kourelis, MD, Yi Lin, MD PhD, Shaji Kumar, MD, Prashant Kapoor, MD

Blood (2016) 128 (22): 5576.

https://doi.org/10.1182/blood.V128.22.5576.5576

Published: 2016

Journal Articles

NEOD001 Demonstrates Organ Biomarker Responses in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction: Results from the Expansion Cohort of a Phase 1/2 Study

Morie A. Gertz, MD MACP, Raymond L. Comenzo, MD, Heather Landau, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Dale B. Schenk, PhD, Spencer D. Guthrie, MBA, Enchi Liu, PhD, Michaela Liedtke, MD

Blood (2016) 128 (22): 644.

https://doi.org/10.1182/blood.V128.22.644.644

Published: 2016

Journal Articles

Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response

Michaela Liedtke, MD, Raymond L. Comenzo, MD, Heather Landau, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Dale B. Schenk, PhD, Spencer D. Guthrie, MBA, Enchi Liu, PhD, Morie A. Gertz, MD MACP

Blood (2016) 128 (22): 647.

https://doi.org/10.1182/blood.V128.22.647.647

Published: 2016

Journal Articles

Presentation and Outcomes of Localized Amyloidosis: The Mayo Clinic Experience

Taxiarchis Kourelis, MD, Francis Buadi, MD, Morie A Gertz, MD, Shaji Kumar, MD, Martha Q. Lacy, MD, Prashant Kapoor, MD, Ronald S. Go, MD, John A. Lust, MD PhD, Suzanne R. Hayman, MD, S. Vincent Rajkumar, Steven R. Zeldenrust, MD PhD, Stephen J. Russell, MD PhD, David Dingli, MD PhD FRCP, Yi Lin, MD PhD, Nelson Leung, MD, Robert A. Kyle, MD, Wilson I. Gonsalves, MD, Angela Dispenzieri, MD

Blood (2015) 126 (23): 4197.

https://doi.org/10.1182/blood.V126.23.4197.4197

Published: 2015

Journal Articles

Natural History of Amyloidosis Isolated to Fat and Bone Marrow Aspirate

Rajshekhar Chakraborty, MBBS, Morie A. Gertz, MD, Angela Dispenzieri, MD, Wilson I. Gonsalves, MD, Ronald S. Go, MD, Suzanne R. Hayman, MD, Yi L. Hwa, NP, Prashant Kapoor, MD, Robert A. Kyle, MD, Martha Q. Lacy, MD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Stephen J. Russell, MD PhD, Steven R. Zeldenrust, MD, PhD, Shaji Kumar, MD

Blood (2015) 126 (23): 5303.

https://doi.org/10.1182/blood.V126.23.5303.5303

Published: 2015

Journal Articles

Dose-Dependent Progressive Immunotherapeutic Clearance of Systemic Amyloid Deposits By Repeated Doses of Antibody to Serum Amyloid P Component (SAP)

Mark B Pepys, MDPhDFRS FMedSci, Louise M Cookson, BSc, Sharon V Barton, BSc MSc, Alienor C Berges, PharmD, Thirusha Lane, RN MSc, David Hutt, BAppSc, Marianna Fontana, MD, James C Moon, MD, Julian D Gillmore, MDPhDFRCP, Ashutosh Wechalekar, MDFRCPath FRCP, Philip N Hawkins, MDPhDFMedSci, Duncan B Richards, DM FRCP

Blood (2015) 126 (23): 1836.

https://doi.org/10.1182/blood.V126.23.1836.1836

Published: 2015

Journal Articles

NEOD001 Specifically Binds Aggregated Light Chain Infiltrates in Multiple Organs from Patients with AL Amyloidosis and Promotes Phagocytic Clearance of AL Aggregates in Vitro

Wagner Zago, Mark Renz, Ronald Torres, Philip J. Dolan, Robin M. Barbour, Joshua R. Salmans, Paul J. Shughrue, Dale Schenk, Gene G. Kinney

Blood (2015) 126 (23): 3016.

https://doi.org/10.1182/blood.V126.23.3016.3016

Published: 2015

Journal Articles

Diagnostic Value of Minor Salivary Glands Biopsy in Systemic Amyloidosis

Giacinto La Verde, Maria Paola Bianchi, Giusy Antolino, Giulia Galassi, Francescaromana Festuccia, Giorgio Bandiera, Armando Bartolazzi, Paolo Menè, Agostino Tafuri, MD

Blood (2015) 126 (23): 5381.

https://doi.org/10.1182/blood.V126.23.5381.5381

Published: 2015

Journal Articles

Hereditary systemic immunoglobulin light-chain amyloidosis

Merrill D. Benson, Juris J. Liepnieks, Barbara Kluve-Beckerman

Blood (2015) 125 (21): 3281–3286.

https://doi.org/10.1182/blood-2014-12-618108

Published: 2015

NARROW

Clinical Characteristics, Treatment Regimens and Survival in Elderly Patients with AL Amyloidosis in a Tertiary Referral Center

Localized Pulmonary Amyloidosis: A Single Institution Experience

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

Prognosis of Patients with Waldenström Macroglobulinemia: A Simplified Model

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Personalizing Amyloidosis Therapy with Real Time PET Imaging of Fibril-Reactive Monoclonal Antibody Cael-101

Risk Stratification of Smoldering Multiple Myeloma in the Light of the Revised IMWG Diagnostic Criteria

Patterns of Treatment Failure in Systemic Light Chain Amyloidosis with Long-Term Survival after Chemotherapy

Outcome of Very Young (≤ 40 years) Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Case Control Study

NEOD001 Demonstrates Organ Biomarker Responses in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction: Results from the Expansion Cohort of a Phase 1/2 Study

Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response

Presentation and Outcomes of Localized Amyloidosis: The Mayo Clinic Experience

Natural History of Amyloidosis Isolated to Fat and Bone Marrow Aspirate

Dose-Dependent Progressive Immunotherapeutic Clearance of Systemic Amyloid Deposits By Repeated Doses of Antibody to Serum Amyloid P Component (SAP)

NEOD001 Specifically Binds Aggregated Light Chain Infiltrates in Multiple Organs from Patients with AL Amyloidosis and Promotes Phagocytic Clearance of AL Aggregates in Vitro

Diagnostic Value of Minor Salivary Glands Biopsy in Systemic Amyloidosis

Hereditary systemic immunoglobulin light-chain amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only